EFTA02583943

From: Boris Nikolic < Sent: Thursday, May 8, 2014 11:23 AM To: Jeffrey Epstein (jeevacation@qmail.com) Subject: FW: Small part of A BIG DEAL This is one I missed &=8211; remember this needed to be a fourth deal to the fund with Yuri.=/o:p> Not sure if Yuri went =n. How long are you in NY=? B From: Eli Casdin Sent: Thursday, May 8, 2014 7:14 AM To: Boris Nikolic Subject: Small part of A BIG DEAL Hi Boris, Apologies for my barrage of emails recently but I wa=ted to call out our latest private investment into Flatiron Health. We wer= extremely excited to be included in the $130m Google led financing of the=company. With the capital raised Flatiron Health is acquiring Altos Solutions and once combined, will becom= the world's largest single source of structured real-world oncology=data and intelligence. This is an example of the big data solutions we disc=ssed in our most recent partners letter. It represents a huge step forward=in driving the personalization of oncology treatments and has the potentia= to bend the curve on costs while at the same time improving patient outcomes. As Bill Maris, managing=partner of Google Ventures commented in the WSJ reporting "We don :=17;t generally make investments of $100-plus million, when we do make an i=vestment of this size, it means we really believe in the team, and the product, and the good that it can do for the world.&#=221; We couldn't agree more and look forward to upd=ting you on the company's progress in the coming quarters. Please fi=d a link here to the WSJ online dispatch Google Ventures Leads $130m Round For Big Data Medical Software Company Fla=iron Health <http://blogs.wsj.com/venturecapital/2014/05/07/google-ventures-l=ads-130m-round-for-big-data- medical-software-company-flatiron-healthh Regards, EFTA_R1_01762418 EFTA02583943 El= Casdin Ca=din Capital, LLC 13=0 Avenue of the Americas, Suite 1140 Ne= York, NY 10019 T.212-897-5438 C.212-300-5575=/p> <http://loopeer12.appspot.com/Cascapital> This e-mail and any attachments are confidential and may =e legally privileged and neither confidentiality nor privilege is waived o= lost by any transmission in error. Any use, printing, copying or disclosure by non-intended recipients is str=ctly prohibited. If you are a non-intended recipient, please delete =his e-mail and any attachments and notify the sender immediately by e-mail= This message is provided for informational purposes and should not be construed as a solicitation or offer to buy or =ell securities or any other financial instrument. Unless otherwise stated, any views expressed in this message are those of the individual send=r and do not necessarily reflect those of Casdin Capital, LLC, its subsidiaries or affiliates ("Casdinc;). Past performance is not indicative of future results.=/span> Information disclosed in any responses to this email, inc=uding any information contained in any attachments, may be used by Casdin =n connection with its business and therefore must not contain any material, nonpublic information about any c=mpany, whether publicly traded or privately held, or any information to wh=ch the person responding to this email is under a duty of confidentiality =r trust not to disclose. By responding to this email, you acknowledge and agree to comply with the conditions contained in the preceding sentence. Due to the electronic nature of email, there is a risk th=t the information contained in this message has been modified. Conse=uently, Casdin can accept no responsibility or liability as to the completeness or accuracy of the information.</=:p> 2 EFTA_R1_01762419 EFTA02583944